JPRN-UMIN000014462尚未招募未知
Phase I/II study of docetaxel/CDGP/5-FU for advanced or recurrent esophageal cancer - Phase I/II study of DNF for advanced or recurrent esophageal cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) history of drug hypersensitivity. (2) active concomitant malignancy. (3) serious complications (severe heart disease, active infection) (4) pregnant or lactating females. (5) The investigator considers not suitable for the study.
研究者
相似试验
已完成
不适用
Phase I/II study of docetaxel/nedaplatin/5-FU for advanced esophageal cancerEsophageal cancerJPRN-UMIN000006615Chiba University40
已完成
2 期
Phase II study of Docetaxel and CDDP and 5-FU for metastatic esophageal cancerEsophageal cancer with distant metastasis (Stage IVb or stage IVa with N4)JPRN-UMIN000002180OGSG45
已完成
2 期
Phase II study of Docetaxel and CDDP and 5-FU for metastatic esophageal cancerPatients to be registered Esophageal cancer with distant metastasis (Stage IVb or stage IVa with N4)JPRN-UMIN000000821OGSG45
已完成
不适用
Phase 1/2 Study of Docetaxel, CDDP and 5-FU therapy in Patients With Unresectable or Recurrent Esophageal Cancernresectable or recurrent esophageal cancerJPRN-UMIN000003633Department of Surgery, Graduate School of Medicine, Osaka University49
尚未招募
不适用
A phase II trial of neoadjuvant docetaxel/5-FU/cisplatin in combination with prophylactic Pegteograstim in unresectable, locally advanced nasal cavity/paranasal squamous cell carcinoma (SCC)NeoplasmsKCT0003377The Catholic University of Korea, St. Vincent's Hospital28